Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors-Reference-Cited by-同舟云学术

Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors

Published:2018-11-01 Issue:11 Volume:4 Page:1597
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Singh Simron¹,Moody Lesley²,Chan David L.¹,Metz David C.³,Strosberg Jonathan⁴,Asmis Timothy⁵,Bailey Dale L.⁶,Bergsland Emily⁷,Brendtro Kari⁸,Carroll Richard⁹,Cleary Sean¹⁰,Kim Michelle¹¹,Kong Grace¹²,Law Calvin¹³,Lawrence Ben¹⁴,McEwan Alexander¹⁵,McGregor Caitlin¹⁶,Michael Michael¹⁷,Pasieka Janice¹⁸,Pavlakis Nick¹⁹,Pommier Rodney²⁰,Soulen Michael²¹,Wyld David²²,Segelov Eva²³,

Affiliation:

1. Department of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

2. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada

3. Perelman School of Medicine, Department of Gastroenterology, University of Pennsylvania, Philadelphia

4. Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Centre, Tampa, Florida

5. Department of Internal Medicine, University of Ottawa, Ottawa, Ontario, Canada

6. Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, Australia

7. Department of Medical Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco

8. North American Neuroendocrine Tumor Society, Albany, New York

9. Department of Endocrinology, Wellington Regional Hospital, Wellington, New Zealand

10. Department of Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada

11. Department of Gastroenterology, Mount Sinai Hospital, New York, New York

12. Department of Nuclear Medicine, Peter MacCullum Cancer Centre, Melbourne, Australia

13. Department of Surgery, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

14. Department of Medical Oncology, Auckland Hospital, Auckland, New Zealand

15. Department of Oncology, University of Alberta, Edmonton, Alberta, Canada

16. Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

17. Department of Medical Oncology, Peter MacCullum Cancer Centre, Melbourne, Australia

18. Department of Surgery, Tom Baker Cancer Centre, Calgary, Alberta, Canada

19. Department of Medical Oncology, Royal North Shore Hospital, Sydney, Australia

20. Department of Surgery, Oregon Health & Science University, Portland

21. Perelman School of Medicine, Department of Medical Imaging, University of Pennsylvania, Philadelphia

22. Department of Medical Oncology, Royal Brisbane and Women’s Hospital, Queensland, Australia.

23. Department of Medical Oncology, Monash University, Clayton, Australia

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Reference39 articles.

1. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the united states.;Dasari;JAMA Oncol,2017

2. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes.;Hallet;Cancer,2015

3. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement.;Meyerhardt;J Clin Oncol,2013

4. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.;Senkus;Ann Oncol,2013

5. Computed tomography—an increasing source of radiation exposure.;Brenner;N Engl J Med,2007

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation Exposure from GEP NET Surveillance;Cancers;2024-01-19

2. ASO Practice Guidelines Series: Surgical Management of Gastrointestinal (Midgut) Neuroendocrine Neoplasms;Annals of Surgical Oncology;2024-01-02

3. Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced Disease;Cancers;2024-01-01

4. Surgery as a Principle and Technical Consideration for Primary Tumor Resection of Small Bowel Neuroendocrine Tumors;Annals of Surgical Oncology;2023-11-25

5. Optimal surgical approach for digestive neuroendocrine neoplasia primaries: Oncological benefits versus short and long-term complications;Best Practice & Research Clinical Endocrinology & Metabolism;2023-09